(Updated - May 5, 2026 7:51 AM EDT)

Canaccord analyst Kyle Mikson lowered the price target on GeneDx (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE